Eli Lilly (LLY) Payables (2009 - 2026)
Eli Lilly posted quarterly Payables of $5.0 billion for Q1 2026, up 46.11% year-on-year from $3.4 billion in Q1 2025, and down 6.51% on a QoQ basis from $5.4 billion in Q4 2025.
Eli Lilly (LLY) has 18 years of Payables data on file, last reported at $5.0 billion in Q1 2026.
- For the quarter ending Q1 2026, Payables rose 46.11% year-over-year to $5.0 billion; the trailing twelve-month figure through Mar 2026 stood at $5.0 billion (up 46.11% YoY), and the FY2025 full-year result was $5.4 billion, up 17.57% from the prior year.
- Payables for Q1 2026 stood at $5.0 billion, down from $5.4 billion in the prior quarter.
- Across five years, Payables topped out at $5.4 billion in Q2 2025 and bottomed at $1.4 billion in Q1 2022.
- The 5-year median for Payables is $3.4 billion (2025), against an average of $3.4 billion.
- The widest annual swing landed in 2022, when Payables fell 12.58%; it then soared 47.66% in 2025.
- A 5-year view of Payables shows it stood at $2.9 billion in 2022, then climbed by 27.82% to $3.8 billion in 2023, then advanced by 21.43% to $4.6 billion in 2024, then increased by 17.57% to $5.4 billion in 2025, then declined by 6.51% to $5.0 billion in 2026.
- The last three Payables figures came in at $5.0 billion (Q1 2026), $5.4 billion (Q4 2025), and $4.3 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 5.03 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 27.92 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 33.77 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 6.01 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 2.94 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 645.00 Mn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 4.51 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 4.23 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | 24.45 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.03 Bn |
| Dec 31, 2025 | 5.38 Bn |
| Sep 30, 2025 | 4.26 Bn |
| Jun 30, 2025 | 5.42 Bn |
| Mar 31, 2025 | 3.44 Bn |
| Dec 31, 2024 | 4.58 Bn |
| Sep 30, 2024 | 2.89 Bn |
| Jun 30, 2024 | 4.10 Bn |
| Mar 31, 2024 | 2.47 Bn |
| Dec 31, 2023 | 3.77 Bn |
| Sep 30, 2023 | 2.44 Bn |
| Jun 30, 2023 | 3.49 Bn |
| Mar 31, 2023 | 2.02 Bn |
| Dec 31, 2022 | 2.95 Bn |
| Sep 30, 2022 | 1.68 Bn |
| Jun 30, 2022 | 2.54 Bn |
| Mar 31, 2022 | 1.43 Bn |
| Dec 31, 2021 | 2.56 Bn |
| Sep 30, 2021 | 1.57 Bn |
| Jun 30, 2021 | 2.37 Bn |
| Mar 31, 2021 | 1.64 Bn |
| Dec 31, 2020 | 2.38 Bn |
| Sep 30, 2020 | 1.43 Bn |
| Jun 30, 2020 | 1.25 Bn |
| Mar 31, 2020 | 1.21 Bn |
| Dec 31, 2019 | 2.08 Bn |
| Sep 30, 2019 | 1.11 Bn |
| Jun 30, 2019 | 1.79 Bn |
| Mar 31, 2019 | 1.17 Bn |
| Dec 31, 2018 | 1.86 Bn |
| Sep 30, 2018 | 1.28 Bn |
| Jun 30, 2018 | 1.90 Bn |
| Mar 31, 2018 | 1.27 Bn |
| Dec 31, 2017 | 2.00 Bn |
| Sep 30, 2017 | 1.20 Bn |
| Jun 30, 2017 | 1.80 Bn |
| Mar 31, 2017 | 1.22 Bn |
| Dec 31, 2016 | 1.90 Bn |
| Sep 30, 2016 | 1.16 Bn |
| Jun 30, 2016 | 1.75 Bn |
| Mar 31, 2016 | 1.15 Bn |
| Dec 31, 2015 | 1.88 Bn |
| Sep 30, 2015 | 1.18 Bn |
| Jun 30, 2015 | 1.68 Bn |
| Mar 31, 2015 | 1.18 Bn |
| Dec 31, 2014 | 1.66 Bn |
| Sep 30, 2014 | 1.02 Bn |
| Jun 30, 2014 | 1.65 Bn |
| Mar 31, 2014 | 2.15 Bn |
| Dec 31, 2013 | 2.66 Bn |
| Sep 30, 2013 | 1.25 Bn |
| Jun 30, 2013 | 2.69 Bn |
| Mar 31, 2013 | 2.00 Bn |
| Dec 31, 2012 | 1.74 Bn |
| Sep 30, 2012 | 1.34 Bn |
| Jun 30, 2012 | 1.75 Bn |
| Mar 31, 2012 | 1.26 Bn |
| Dec 31, 2011 | 3.19 Bn |
| Sep 30, 2011 | 2.78 Bn |
| Jun 30, 2011 | 3.26 Bn |
| Mar 31, 2011 | 2.72 Bn |
| Dec 31, 2010 | 1.77 Bn |
| Sep 30, 2010 | 1.19 Bn |
| Jun 30, 2010 | 1.52 Bn |
| Mar 31, 2010 | 984.10 Mn |
| Dec 31, 2009 | 1.53 Bn |
| Jun 30, 2009 | 2.49 Bn |